AUTORADIOGRAPHY OF DOPAMINE-D2 RECEPTORS USING [H-3] YM-09151-2

被引:30
作者
COX, RF [1 ]
WASZCZAK, BL [1 ]
机构
[1] NORTHEASTERN UNIV,COLL PHARM & ALLIED HLTH PROFESS,PHARMACOL SECT,312 MUGAR BLDG,BOSTON,MA 02115
关键词
3H]YM-09151-2; AUTORADIOGRAPHY; DOPAMINE-D2; RECEPTORS; BENZAMIDES (SUBSTITUTED); BASAL GANGLIA; BRAIN (RAT);
D O I
10.1016/0014-2999(91)90642-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rat brain dopamine D2 receptors were labeled autoradiographically using the potent and selective benzamide, [H-3]YM-09151-2. Saturation binding data, quantified from autoradiograms, showed specific binding of [H-3]YM-09151-2 to striatal D2 receptors with a K(D) of 82 pM and B(max) of 0.696 pmol/mg protein. Binding equilibrium occurred within 3 h, and a dissociation constant of 15 pM was obtained in kinetic studies. Antagonist competition curves were monophasic and displayed an order of potency expected for D2 receptors: (+)-butaclamol > (-)-sulpiride > SCH 23390 > mianserin. Competition by dopamine resulted in a shallow, biphasic displacement curve. The distribution of [H-3]YM-09151-2 binding sites matched the known pattern for D2 receptors, with dense labeling in striatum, olfactory tubercles and nucleus accumbens, and moderate levels in substantia nigra pars compacta and mamillary nuclei. Much lower levels of non-specific binding were observed than are typically obtained when using [H-3]spiperone as the ligand. The coincident high affinity and selectivity of [H-3]YM-09151-2 for D2 sites should make this compound a preferred choice for tritium-based D2 autoradiography.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 10 条
[1]  
ALTAR CA, 1985, J PHARMACOL EXP THER, V233, P527
[2]  
BOYSON SJ, 1986, J NEUROSCI, V6, P3177
[3]   AUTORADIOGRAPHIC LOCALIZATION OF [H-3]-LABELED SULPIRIDE BINDING-SITES IN THE RAT-BRAIN [J].
GEHLERT, DR ;
WAMSLEY, JK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 98 (02) :311-312
[4]  
HOWLETT DR, 1979, MOL PHARMACOL, V15, P506
[5]   DOPAMINE-D-2 RECEPTORS IN RAT CAUDATE-PUTAMEN - THE LATERAL TO MEDIAL GRADIENT DOES NOT CORRESPOND TO DOPAMINERGIC INNERVATION [J].
JOYCE, JN ;
LOESCHEN, SK ;
MARSHALL, JF .
BRAIN RESEARCH, 1985, 338 (02) :209-218
[6]   SPECIFIC INVITRO AND INVIVO BINDING OF H-3-RACLOPRIDE - A POTENT SUBSTITUTED BENZAMIDE DRUG WITH HIGH-AFFINITY FOR DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN [J].
KOHLER, C ;
HALL, H ;
OGREN, SO ;
GAWELL, L .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) :2251-2259
[7]   EFFECTS OF YM-09151-2, A POTENT AND SELECTIVE DOPAMINE-D2 ANTAGONIST, ON THE AMBULATION-INCREASING EFFECT OF METHAMPHETAMINE IN MICE [J].
KURIBARA, H ;
TADOKORO, S .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 52 (03) :489-492
[8]   DOPAMINE-D2 RECEPTORS SELECTIVELY LABELED BY A BENZAMIDE NEUROLEPTIC - [H-3] YM-09151-2 [J].
NIZNIK, HB ;
GRIGORIADIS, DE ;
PRIBAR, I ;
BUCHMAN, O ;
SEEMAN, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (04) :333-343
[9]   COMPARATIVE DISTRIBUTION OF DOPAMINE D-1 AND D-2 RECEPTORS IN THE BASAL GANGLIA OF TURTLES, PIGEONS, RATS, CATS, AND MONKEYS [J].
RICHFIELD, EK ;
YOUNG, AB ;
PENNEY, JB .
JOURNAL OF COMPARATIVE NEUROLOGY, 1987, 262 (03) :446-463
[10]   COMPARISON OF [H-3] YM-09151-2 WITH [H-3] SPIPERONE AND [H-3] RACLOPRIDE FOR DOPAMINE D-2 RECEPTOR-BINDING TO RAT STRIATUM [J].
TERAI, M ;
HIDAKA, K ;
NAKAMURA, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 173 (2-3) :177-182